Page 8 - Indian Healthcare

ADB approves $170 million loan to strengthen health sector in India

The $170 million policy-based loan will help in the implementation of the government's National Health Policy 2017

India is largest market for Maggi noodles, 6 billion servings sold in FY24

Nestle India also noted that it sold 4.2 billion fingers of popular chocolate KitKat, making India its second-largest market

India to showcase Ayushman Bharat digital mission at World Health Assembly

India will highlight its universal coverage through Ayushman Bharat, public health emergency preparedness and digital health transformations in the country at the World Health Assembly to be held in Geneva from May 27, official sources said on Wednesday. It will also showcase the Arogya Maitri Disaster Management Cube -- an indigenous portable hospital -- equipped with several innovative tools designed to enhance disaster response and medical support at the annual event organized by the World Health Organisation (WHO). The 77th session of the World Health Assembly (WHA) will be held in Geneva from May 27 to June 1. Indian delegation from the Ministry of Health and Family Welfare is being led by Union Health Secretary Apurva Chandra. Representatives from 194 countries will participate in the event to structure the global health ecosystem. The theme for this year's WHA is "All for Health, Health for All". The WHA comprises sessions in three main committees -- Plenary, Committee A and

Study on Covaxin should revise statement on conclusions for clarity

It likely overstates actual risks associated with the vaccine and conflates common illnesses with vaccine-related adverse effects

Zydus Wellness Q4: Net profit up 3.44% to Rs 150 cr, revenue at 782 cr

Zydus Wellness Ltd on Tuesday reported a 3.44 per cent rise in consolidated net profit at Rs 150.3 crore in the fourth quarter ended March 31, 2024. The company had posted a consolidated net profit of Rs 145.3 crore in the same quarter of the previous fiscal, Zydus Wellness said in a regulatory filing. Consolidated total revenue from operations in the quarter under review stood at Rs 782.6 crore, as against Rs 713 crore in the corresponding period a year ago, it said. Total expenses were higher at Rs 632.2 crore in the fourth quarter of financial year 2023-24, as compared to Rs 580.2 crore in the year-ago period. For the fiscal ended March 31, 2024 consolidated net profit was at Rs 266.9 crore, as against Rs 310.4 crore in the previous fiscal, the company said. In FY24, consolidated total revenue from operations stood at Rs 2,327.8 crore, as compared to Rs 2,254.8 crore in FY23. The board of directors at their meeting held on May 14, 2024 recommended a final dividend Rs 5 per equ

India's unhealthy truths

Our healthcare is marred by poor infrastructure, negligence, and pharma-doctor collusion. Sumanth C Raman's book exposes all this and more, questioning why it doesn't evoke as much anger in Indians

India premier destination for global clinical trials, says Harvard scholar

India has emerged as a premier destination for conducting global clinical trials, an Indian bureaucrat who is also a Harvard scholar has said, asserting that the pharma industry must recognise the country's intrinsic value as a primary location rather than relegating it to a secondary backup role. Speaking at a recent Bio-Pharma summit in Boston, Dr Mrinalini Darswal, an Indian diplomat who is currently a PhD scholar at Harvard University, said that India "boasts a robust infrastructure, a cadre of seasoned investigators, and cost-effectiveness, collectively rendering it an appealing choice for such endeavours. The present aspirational India under the strong and transformative leadership of our Prime Minister Narendra Modi has emerged as a premier destination for conducting global clinical trials, having streamlined its regulatory framework and elevated its compliance standards to align with international good clinical practices, Darswal said. This starkly contrasts larger economies

Wipro to implement Independent Health's medicare prescription payment plan

Wipro's medicare prescription payment plan platform will streamline prescription payments

Advent to infuse Rs 2,475 crore into Apollo Hospitals' subsidiary

The merger will happen in a phased manner over the next 24-30 months. The combined entity is expected to deliver Rs 25,000 crore of revenue in three years with 7-8 per cent EBITDA

Pakistani teen receives life-saving heart transplant in Chennai hospital

The hospital and Chennai-based NGO helped Pakistani family settle bill of more than Rs 35 lakh for the transplant

All health schemes gradually coming under Ayushman Bharat umbrella

Coverage under India's flagship Ayushman Bharat scheme may double to Rs 10 lakh; scheme may integrate various national and state health programmes

HHCN engages with states to boost preventive care for treating Haemophilia

Prophylactic treatment can reduce number of bleeds per year, improve quality of life, say experts

World Liver Day 2024: History, importance and all that you need to know

World Liver Day gives an opportunity to teach people about the risk factors for liver infection, which incorporate liquor consumption, obesity, viral hepatitis, and certain drugs

Aster DM Healthcare lines up Rs 1k cr to ramp up bed capacity in 3 years

Aster DM Healthcare, which netted around USD 907 million from the sale of its GCC business, looks to plough around Rs 1,000 crore into its expansion plans in India as it targets a bed capacity of over 6,600 in the next three years. The healthcare company plans to add 1,700 beds by 2026-27 through organic and inorganic routes. The company's board last week also approved a special dividend of Rs 118 per share to its shareholders following the booster shot from the divestment of the GCC business. Aster DM Healthcare recently concluded the sale of its GCC businesses for a cash consideration of USD 907.6 million. The record date for determining the entitlement of the shareholders to special dividend is April 23, 2024. Aster DM Healthcare shares rallied more than 14 per cent on Monday to hit a fresh 52-week high on BSE, bucking a weak trend in the broader market. The stock hit a year high of Rs 558.30 per share before closing at Rs 522.75 on BSE, up by 7.13 per cent over the previous ..

Pioneering Thoughts with Dipen Bhuva: A Fusion of Healthcare, Cybersecurity, and AI

.

From jobs to MSP, what has changed in Congress' manifesto from 2019

Lok Sabha elections 2024: The manifesto pledged to conduct a nationwide Socio-Economic and Caste Census to assess caste and sub-caste demographics along with their socio-economic status

C-Section deliveries on the rise in India between 2016 and 2021: Study

The study also revealed that nearly half of all deliveries in private hospitals were C-sections (caesarean sections)

Developed India@2047

Education and health outcomes will need to be improved

Wipro GE Healthcare to invest Rs 8K cr in 5 yrs on medical devices, R&D

Wipro GE Healthcare on Tuesday said it will invest over Rs 8,000 crore in India over the next five years to increase local manufacturing and research and development (R&D) initiatives. The company, a leading global medical technology, pharmaceutical diagnostics, and digital solutions provider, said as a part of the investment, its 'Made in India' PET CT Discovery IQ scanner will be exported to 15 countries. Additionally, locally produced Revolution Aspire CT, Revolution ACT and MR breast coils will be manufactured 'In India for the World', the company said in a statement. The strategic investment bolsters the company's local manufacturing footprint to address the growing domestic and international market. It will also build supply chain resiliency for the organisation, it added. Wipro GE Healthcare Chairman Azim Premji said India is riding the resurgent growth in the healthcare industry and rapidly expanding MedTech sector. "With 'Make in India', we are witnessing an exponential .

Usher in transparency, not price controls

A standard rate chart for hospitals across the country is impractical as it doesn't consider real estate costs that vary widely across locations